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Objective: To evaluate the effectiveness of a new off-pump mitral valve repair technology in restoring valve
competency in a porcine model of acute mitral regurgitation.
Methods: Acute mitral regurgitation was induced in 6 anesthetized pigs by cutting anterior leaflet chordae. Ar-
tificial chordae were then transapically implanted on the prolapsing segment under epicardial echocardiographic
guidance and secured outside the left ventricular apex. All intracardiac manipulations were performed off-pump,
through a stab wound incision on the left ventricular apex.
Results: Cutting the anterior leaflet chordae caused an eccentric, posteriorly directed jet of mitral regurgi-
tation that could be visualized by color Doppler sonography. Implantation of chordae through the left ven-
tricular apex completely eliminated valve regurgitation in 4 animals and reduced regurgitation in 2.
Intraoperative measurement of artificial chordal tensions gave similar values to those reported for native
chordae.
Conclusions: Off-pump, transapical implantation of artificial chordae between a prolapsing anterior mitral valve
leaflet and the left ventricular apex was effective in reducing acutely induced mitral regurgitation. Long-term
studies are planned to assess the stability in this animal model.Video clip is available online.
One of the most frequent causes of severe nonischemic mi-
tral regurgitation (MR) is mitral valve prolapse (MVP). The
prevalence of MVP in the United States is estimated at 2%
to 3% and shows no difference in distribution between men
and women.1 In recent years, the development of new surgi-
cal techniques has made mitral valve (MV) repair, rather
than replacement, the procedure of choice for most MV dis-
eases.2 Despite improvement in clinical outcomes, current
repair procedures are not perfect and surgical procedures still
require the patient to be supported by cardiopulmonary
bypass.3
Implantation of artificial chordae tendineae (ACTs) is
a widely used technique for correction of both posterior
and anterior leaflet prolapse.4
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doi:10.1016/j.jtcvs.2008.09.004188 The Journal of Thoracic and Cardiovascular SuThe new MV repair technology described in this study is
the direct result of previous acute and short-term in vivo ani-
mal studies* and it allows off-pump implantation of ACTs
using a specially designed instrument inserted through the
left ventricular (LV) apex into the LV cavity. ACTs are im-
planted between the prolapsing/flail portion of a leaflet and
the LV apex (Video E1 and Figure 1) without cardiopulmo-
nary bypass and can be adjusted intraoperatively under
echocardiographic guidance. This technology was devel-
oped to explore the feasibility of a transapical approach to
MV repair, with the following added benefits, which may re-
duce operative morbidity during MVP repair: (1) off-pump
procedure; (2) may be performed through a small incision
without full sternotomy; (3) the ability to intraoperatively as-
sess, adjust, and reverse ACT implantation.
This study assesses the feasibility of the system and the
acute echocardiographic and hemodynamic changes during
the procedure.
MATERIAL AND METHODS
Design
The surgical tool for ACT implantation was composed of a handle, to
manipulate and orient the device, and a rigid shaft with a sliding mech-
anism, to grab and securely hold the prolapsing leaflet segment. The
rigid shaft contained the suture, a needle, and a fiberoptic visualization
system. The suture was contained in a channel and formed a continuous
loop. Another channel contained a harpoon-tipped needle (Figure 2),
* Speziali G, Bruce CJ, Gilman G, Potter DD, Daly RC. Totally Endoscopic Intracar-
diac Repairs on a Beating Heart. In: The ISMICS Conference, June 19–21, 2003,
San Francisco, California, and Speziali G, Potter DD, Bruce CJ, Gilman G, Henke
PS, Suddendorf SH, Timmons MJ, Daly RC. Endoscopic, Off-pump Mitral Valve
Repair: Continued Development of a New Technique. In: The ISMICS Conference,
June 19–21, 2004, London, United Kingdom.rgery c January 2009
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ACTs ¼ artificial chordae tendineae
LV ¼ left ventricular
MR ¼ mitral regurgitation
MV ¼ mitral valve
MVP ¼ mitral valve prolapse
used to grab the suture and pull it through the MV leaflet to create a half
hitch around the leaflet edge.
The fiberoptic visualization system consisted of four parallel chan-
nels, built into the instrument shaft, connected to a monitor. The fiberoptics
were arranged around the needle channel in a manner such that the grasped
MV leaflet was pulled against the fiberoptic extremities (Figure 3, A). When
no valve tissue was grasped, the monitor showed four red dots because the
fiberoptics were in direct contact with the blood (Figure 3, B). When theMV
tissue was grasped, the dots turned white because the fiberoptics contacted
tissue, indicating that the ACT insertion point would be at a depth of 3 to 4
mm from the leaflet edge allowing a sufficient line of coaptation. If the mon-
itor showed four white dots, the ‘‘bite’’ on the MV leaflet was optimal (Fig-
ure 3, C). If only the upper two dots turned white, the ‘‘bite’’ on the leaflet
was too shallow. Real time echocardiographic guidance provided sufficient
visual information for the device to capture the valve leaflets in the intended
segment. The fiberoptic system confirmed an adequate ‘‘grasp’’ of the leaf-
let itself. Integration of the two visualization methods enabled successful
and reproducible positioning the ACT in all animals.
In Vivo Study
This study was approved by the University of Pittsburgh’s Institutional
Animal Care and Use Committee, and all animals received humane care
in accordance with the ‘‘Guide for the Care and Use of Laboratory Ani-
mals’’ (National Institutes of Health publication 85-23, revised 1985). Six
Yucatan pigs (body weight, 88 12.2 kg) were anesthetized with ketamine
(2.2 mg/kg), telazol (4.4 mg/kg), and xylazine (2.2 mg/kg) and intubated.The Journal of Thoracic and CAnesthesia was maintained with isoflurane (1%–2%). Lidocaine (100
mg)was given to prevent arrhythmias. The heart was accessed through ame-
dian sternotomy. Heparin (300 units/kg) was administered intravenously.
During the experiments, left atrial pressure, aortic pressure, left ventricular
pressure, and central venous pressure were measured with 5F catheters. The
electrocardiogram was monitored. Epicardial 2-dimensional echocardio-
grams (HP SONOS 1500; Hewlett Packard, Andover, Mass) were obtained
to follow the procedure and assess the final results.
A double pledget-supported purse-string suture was placed on the LV
apex where a stab incision was made. MR was induced by cutting one or
two major native chordae with a custom-made device under echocardio-
graphic guidance. After the existence of MR had been confirmed, the sur-
gical tool for ACT implantation was transapically inserted into the LV
chamber (Figure 1). The prolapsing segment of the MV was grasped under
direct fiberoptic visualization. One or more 5– expanded polytetrafluoro-
ethylene sutures (Gore-Tex; W.L. Gore & Associates, Inc, Flagstaff,
Ariz) were secured to the free edge of the middle scallop of the anterior
leaflet, in a position adjacent to the insertion point of the major strut chor-
dae, which were cut (Figure 1, A). An accuracy of 2 mm or less was com-
monly achieved. After the new ACT was positioned, another loop was
placed around the first one so that if the ACT was malpositioned, it could
be simply retrieved by pulling the second suture, which remained outside
the heart. The lengths of the newly implanted ACTs were adjusted man-
ually and their function was assessed in real time by observing reduction
or disappearance of MR by color Doppler echocardiogram (Figure 4, A
and B). The procedure was repeated until the echocardiogram showed
no residual MR or reduced MR.
The tension of each implanted ACT was then immediately measured
with a digital tensiometer (TX-Series; Tensitron, Longmont, Colo) con-
nected with a USB interface (1208FS; Measurements Computing, Norton,
Mass) to the computer for data acquisition (Labview 7.1 software; National
Instruments, Austin, Tex) and compared with the LV pressure during sev-
eral cardiac cycles. The ACTs were secured outside the heart apex and he-
mostasis was achieved by tying the purse-string suture around the incision
(Figure 1, B).
At the end of the experiment, each animal was monitored for at least
45 minutes and then humanely killed by intravenous administration of po-
tassium chloride (10 mEq/kg). The heart was harvested and the LV openedE
TFIGURE 1. Schematic drawing of the surgical technique. A, The instrument is inserted in the LV cavity and new ACT is implanted on the MV leaflet. B,
ACT in place and secured outside the LV apex.ardiovascular Surgery c Volume 137, Number 1 189
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TFIGURE 2. The open tip of the instrument with the sliding mechanism and
the harpoon-tipped needle.190 The Journal of Thoracic and Cardiovascular Suto inspect both the ACT implantation site and the LV apex where the instru-
ment was inserted.
Statistical Analysis
Hemodynamic data of the continuous variables were summarized and re-
ported as median and interquartile range. The Wilcoxon signed rank test,
a nonparametric equivalent of the paired t test, was used to compare preim-
plant and postimplant data. SPSS version 15.0 software (SPSS Inc, Chicago,
Ill) was used.
RESULTS
All the experiments were successfully conducted off-
pump. No bleeding or tears were observed at the site of
instrument insertion. In all cases, MR could be detected
by color Doppler echocardiogram when one or two major
strut chordae of the MV anterior leaflet were cut. Up to 3
pairs of ACTs per animal were successfully implanted
without damaging the valvular or subvalvular apparatus.
In all cases, there was no need to retrieve the newly im-
planted ACT owing to malpositioning. Postoperative
echocardiography showed no residual MR in 4 cases. InFIGURE 3. Instrument and fiberoptics. A, Opened tip of the instrument with enlighten fiberoptics. B, No valve tissue grasped. Four red dots resulted from the
direct contact of the fiberoptics with the blood. C, MV tissue grasped. The fiberoptics contacting the tissue turned white.rgery c January 2009
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Tthe remaining 2 cases, minimal MR was detected. Figure 5
shows the highlights of the procedure from a typical case.
An eccentric jet was demonstrated by color Doppler echo-
cardiography after cutting the native chordae (Figure 5,
A). The instrument was inserted into the LV chamber
and grabbed the MV anterior leaflet (Figure 5, B). The su-
ture was deployed and the instrument withdrawn from the
LV cavity (Figure 5, C). After appropriate tensioning of
the newly implanted ACT, MR disappeared (Figure 5,
D). During the operation, we used echocardiography to
immediately assess the result and determine the correct
tension to prevent MR (Figure 4). The mean implantation
time for each ACT was 5  1.51 minutes.
Hemodynamic data are shown in Table 1. On the basis of
the P value, the differences between before and after implan-
tation in heart rate and mean aortic pressure could be due to
chance (P> .2). However, the differences between before
and after implantation in systolic LV pressure, mean left
FIGURE 4. ACTs tensioning. A, Neoimplanted, nontensioned ACTs with
MR. B, ACT length judged in real time by observing reduction or disappear-
ance of MR with color Doppler echocardiogram. Ao, Aorta; LA, left atrium;
LV, left ventricle; ACT, artificial chordae tendineae.The Journal of Thoracic and Catrial pressure, and mean central venous pressure values
are statistically significant.
The numerical relationship between ACT tension (in
Newtons, N) and LV pressure averaged 0.95 (range 0.7–
1.1). Chordal tension measurements were of the same order
of magnitude as those measured in nativeMV chordae5,6 and
in ACTs in an in vitro simulation.7 Necroscopic inspection
of both MV leaflets at the ACT insertion point and subvalv-
ular apparatus did not show any anatomic abnormality or
laceration (Figure 6, A and B).
DISCUSSION
Since 1985, expanded polytetrafluoroethylene ACTs
have been used for MVP repair.8 ACTs in MV positions
do not shrink or break and become covered by an intimal
tissue like native chordae.9 According to Phillips and col-
leagues,10 chordal replacement has superior outcomes af-
ter a long-term follow-up than chordal shortening and is
relatively simple and reproducible. The present study
investigated the feasibility of a new technology for MV
repair by ACT implantation. In this animal model, trans-
apical implantation of ACTs corrected surgically induced
acute MR. In all animals, the experiments were performed
off-pump. All intracardiac manipulations of the instrument
and deployment of the ACTs were monitored through
real-time echocardiography.
The newly implanted ACTs were subjected to the same
ranges of tension as those of native chordae measured in pre-
vious studies.5-7 Thus, even when the ACTs are implanted
and secured with different orientation from that of native
chordae, they are subjected to physiologic tension levels
and do not interfere with the MV subvalvular apparatus.
Therefore, the LV apex appears to be a suitable location to
anchor transapically implanted ACTs.
Indications for this new surgical treatment should fo-
cus primarily on patients with MVP who have redundant
leaflet structure and motion, with MR attributed mainly
to the protrusion of the leaflet tissue into the left atrial
chamber during systole resulting in lack of leaflet coap-
tation and MR characterized by an eccentric jet. In
fact, the device has been used to address MR in 3 pa-
tients, who are currently under evaluation for an appro-
priate follow-up period.y More important, this device is
an important step in evolving the technology for hybrid
procedures in mitral valve repair. The device is not in-
tended to treat MR arising from ischemic or dilated car-
diomyopathy pathology.
ySpeziali G, Bruce CJ, Ricci D, Daly RC. Off-Pump Placement of Artificial Chordae
Tendinae Corrects Mitral Regurgitation: Early Clinical Experience. In The ISMICS
Conference, June 6-9, 2007, Rome, Italy, and Speziali G. Transapical Chordae
Replacement. In The EACTS Conference, September 15–19, 2007, Geneva,
Switzerland.ardiovascular Surgery c Volume 137, Number 1 191
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TFIGURE 5. Surgical procedure highlights. A, MV eccentric jet is demonstrated by color Doppler sonography after cutting native chordae. B, Instrument ws
inserted in the LV and grabbed theMV anterior leaflet. C, ACT in place after instrument withdrawal. D, Final result with no residualMR after ACT tensioning.
Ao, Aorta; LA, left atrium; LV, left ventricle; ACT, artificial chordae tendineae.Study Limitations
In this study, MR was induced by cutting one or two
major native chordae on the anterior leaflet of an other-
wise normal MV. Annular dilatation was not present,
and the valve leaflets were thin and structurally normal.
The MV chordal injury caused an eccentric, posteriorly
directed jet of MR that could be visualized by color
Doppler sonography. Assessing severity of eccentric MR
by color Doppler sonometry is limited inasmuch as the
jet area can underestimate the severity of the MR. In ad-
dition, more quantitative methods such as measuring the
vena contracta or the proximal isovelocity surface area
method are limited for this type of MR. Despite these
limitations, epicardial echocardiography was able to
show the mitral injury with a flail segment, color Doppler
TABLE 1. Hemodynamic data
Preimplant
data,*
median
(IQR)
Postimplant
data,
median
(IQR)
P value
(Wilcoxon
signed rank
test)
HR (beats/min) 73.5 (6.75) 69.0 (9.75) .345
AoPm (mm Hg) 78.5 (32.5) 85.0 (35.0) .292
LVPsys (mm Hg) 92.0 (16.0) 95.0 (12.0) .042
LAPm (mm Hg) 17.0 (3.0) 15.0 (3.0) .039
CVPm (mm Hg) 11.0 (3.0) 9.0 (2.75) .041
AoPm, Mean aortic pressure; CVPm, mean central venous pressure; HR, heart rate;
IQR, interquartile range; LAPm,mean left atrial pressure; LVPsys, systolic left ventric-
ular pressure. *Preimplant data were collected after mitral regurgitation was induced.192 The Journal of Thoracic and Cardiovascular Sursonography of the resultant MR, and the repair of the mi-
tral leaflet with resolution of the MR.
This study was designed as a preliminary evaluation of
a new technology that allows implantation of ACTs
through the LV apex. Because the anchorage of the chor-
dae to the apex could lead to changes in the native anat-
omy, such as the subvalvular apparatus and LV
geometry, a detailed longer-term study on postoperative
performance and remodeling is currently being per-
formed. Our preliminary results suggest no changes on
short-term follow-up (<1 month) (Speziali G, Bajona P.
Endoscopic, Off-Pump Mitral Valve Repair: A Long-
Term Study; unpublished results). Further evaluation in
a long-term survival model will be performed to explore
both the potential and the contraindications of this new
technique and to assess the stability of the ACT connec-
tion to the MV leaflets.
CONCLUSIONS
From the present study, we can conclude that off-pump
ACT implantation from the LV apex is a feasible and repro-
ducible procedure. In all cases, ACTs were successfully im-
planted with a specially designed surgical instrument. This
innovative surgical procedure reduced or eliminated MR
and the LV apex was demonstrated to be a suitable anchor-
ing spot for newly implanted ACTs.
We thank Dr Shannon Wyszomierski for her assistance in edit-
ing this article and Mrs Sujatha Raghu, MBBS, MPH, for the sta-
tistical analysis review.gery c January 2009
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TFIGURE 6. Postoperative inspection of valvular and subvalvular appara-
tus and newly implanted ACTs. A, Open view of the LV with two native
chordae cut, an implanted ACT and LV apex with pledget-supported
purse-string suture, and ACT anchorage. B, LV apical view of the MV
with one native chordae cut and an implanted ACT. NC cut,Native chordae
cut; ACT, artificial chordae tendinae; PML, posterior mitral valve leaflet;
AML, anterior mitral valve leaflet; LV apex, left ventricular apex.The Journal of Thoracic and CReferences
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